IceCure Medical reported Q1 2024 revenue of $736.4K, missed analyst consensus of $1.0M by $280.7K. Diluted EPS came in at $-0.08.
Filings will appear here once submitted to SEC EDGAR.
Common questions about IceCure Medical's Q1 2024 earnings report.
IceCure Medical (ICCM) reported Q1 2024 earnings on May 28, 2024 before market open.
IceCure Medical reported revenue of $736.4K and diluted EPS of $-0.08 for Q1 2024.
Revenue missed the consensus estimate of $1.0M by $280.7K. EPS beat the consensus estimate of $-0.08 by $0.00.